| Literature DB >> 26680001 |
Gilles Mourier1, Miguel Salinas2, Pascal Kessler1, Enrico A Stura1, Mathieu Leblanc1, Livia Tepshi1, Thomas Besson2, Sylvie Diochot2, Anne Baron2, Dominique Douguet3, Eric Lingueglia4, Denis Servent5.
Abstract
Mambalgins are peptides isolated from mamba venom that specifically inhibit a set of acid-sensing ion channels (ASICs) to relieve pain. We show here the first full stepwise solid phase peptide synthesis of mambalgin-1 and confirm the biological activity of the synthetic toxin both in vitro and in vivo. We also report the determination of its three-dimensional crystal structure showing differences with previously described NMR structures. Finally, the functional domain by which the toxin inhibits ASIC1a channels was identified in its loop II and more precisely in the face containing Phe-27, Leu-32, and Leu-34 residues. Moreover, proximity between Leu-32 in mambalgin-1 and Phe-350 in rASIC1a was proposed from double mutant cycle analysis. These data provide information on the structure and on the pharmacophore for ASIC channel inhibition by mambalgins that could have therapeutic value against pain and probably other neurological disorders.Entities:
Keywords: X-ray crystallography; acid sensing ion channel (ASIC); mambalgin; pain; peptide chemical synthesis; peptide interaction; sodium channel; structural model; toxin
Mesh:
Substances:
Year: 2015 PMID: 26680001 PMCID: PMC4742732 DOI: 10.1074/jbc.M115.702373
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157